xAnts

xAnts

en-ZA
  • Popular weight-loss drugs linked to new health risks and benefits
  • Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
  • High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs—but it can be critical for retaining talent
  • Lifestyle changes are key after study links Ozempic to lower Alzheimer's risk: Expert
  • Cardiovascular health disparities persist in puzzling ways, studies find
  • Loading...